National Cancer Institute

Dallas’ Pieces Technologies Gets $2M from National Cancer Institute to Advance Conversational AI for Cancer Patients

by | Oct 30, 2024
With the NCI funding—which follows Piece's $25 million growth financing round announced in September—Pieces will partner with Cleveland-based MetroHealth to deploy a new conversational AI agent for cancer patients called "PiecesChat."
MORE
Lantern Pharma cancer
Lantern Pharma Teams Up with National Cancer Institute to Predict Drug Effectiveness on Tumors
by | Oct 7, 2019
This alum of Dallas startup accelerator Health Wildcatters is working with the National Cancer Institute's Developmental Therapeutics Branch on precision research and treatments.
MORE
Beat AML
Simmons Cancer Center Joins Beat AML Trial
by | Jun 16, 2017
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern is one of 12 NCI-designated in the Beat AML trial, and the only site in Texas
MORE